Citadel Advisors’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
Other funds holding TTOO
GCP
VF
TRCT
Citadel Advisors's TTOO Position: Q4 2023 in Review
Citadel Advisors sold out of T2 Biosystems, Inc (TTOO) in Q4 2023, closing a stake of 10 shares — an estimated $221 sold.
Citadel Advisors first reported a position in TTOO in Q4 2015 and held it in 18 quarters. The position peaked at $434K in Q1 2021. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.
- Citadel Advisors reported no remaining T2 Biosystems, Inc position as of Q4 2023 after selling out during the quarter.
- Citadel Advisors sold 10 T2 Biosystems, Inc shares in Q4 2023, an estimated $221.
- Citadel Advisors first reported a position in T2 Biosystems, Inc in Q4 2015 and held it in 18 quarters.
- Citadel Advisors's T2 Biosystems, Inc position peaked at $434K in Q1 2021.
- 21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.